UPDATE: Raymond James Downgrades Amedisys (AMED) to Market Perform
Tweet Send to a Friend
(Updated - October 27, 2022 7:37 AM EDT)
Raymond James analyst John Ransom downgraded Amedisys (NASDAQ: AMED) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst John Ransom downgraded Amedisys (NASDAQ: AMED) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
